Allergan Unanimously Rejects Revised Valeant Bid

June 10 (Bloomberg) -- Bloomberg’s Betty Liu reports that Allergan’s board has unanimously rejected an improved offer from Valeant, claiming it undervalues the company. She speaks on Bloomberg Television’s “In The Loop.”
CBS to Offer Showtime on Broadband
59:34 - Bloomberg's Mark Crumpton and Scarlet Fu report on today's top news stories. They speak on “Bloomberg Markets.” (Source: Bloomberg)
  • Fed: Economy Expanded From Early April to Late May
  • Analyst Crackdown Not Improving Earnings Forecasts: Study
  • How Should FIFA Manage Crisis?